Research Article

Evaluation of the Periodontal Status in Acromegalic Patients: A Comparative Study

Table 1

Detailed clinical description of the 32 acromegalic patients studied.

PatientAge
(years)
SexMedication with
CBRALPGBBAAADPGHTPATTSCIGF-I
(ng/mL)
IGFBP-3
(ng/mL)
Comorbidities

I61Male++++133 2980TH
II47Male2045870K
III61Male7278850D, H, C
IV57Male+++1383960H
V48Male1183540
VI70Male++48.21910
VII52Male75.45420
VIII48Male92.12940H, TH
IX52Male+++1043560TH
X67Male++6245640H
XI53Male++2496180D, H, C
XII44Male++1825180TH, C
XIII49Male3146260
XIV64Male++1834780
XV42Male1483680
XVI62Male++3726040H
XVII41Female1744090
XVIII68Female1915450TH
XIX61Female++++1096880D, TH, C
XX67Female+++++2707510D, TH
XXI63Female++++1425120H, TH
XXII36Female+873800
XXIII47Female++1264300H, TH
XXIV23Female1585120
XXV69Female1434700
XXVI38Female++1804210
XXVII63Female+++++1994980D, TH
XXVIII59Female++++++86.23880
XXIX50Female++2315430C
XXX59Female+1004390D
XXXI65Female++++++412220TH, C
XXXII70Female+++1635550TH

CB: calcium channel blocker; RA: medications affecting the renin-angiotensin system (C09); LP: lipid medication (C10); GB: gall bladder (A05A); BAA: beta-adrenoreceptor antagonists (C07A); AD: androgens (G03B); PG: hormones for pituitary gland (H01A, H01B); HT: hormones for hypothalamus (H01C); PA: psychoanaleptics (N06); TT: thyroid therapy (H03); SC: systemic corticosteroids (H02A).
D: self-reported diabetes mellitus or antidiabetic therapy (ATC code: A10), H: hypertension (defined as diastolic >90 mmH or systolic pressure >140 mmHg or hypertensive medication (ATC code: C02)); K: self-reported chronic kidney disease; TH: self-reported chronic thyroid disease; C: self-reported cancer.
IGF-I: insulin-like growth factor-1.